Amphastar Pharmaceuticals, Inc. financial data

Symbol
AMPH on Nasdaq
Location
Rancho Cucamonga, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 331% % 13%
Quick Ratio 100% % 39%
Return On Equity 13% % -43%
Return On Assets 6% % -42%
Operating Margin 20% % -31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 45,370,171 shares -3.8%
Common Stock, Shares, Outstanding 45,645,497 shares -4.1%
Entity Public Float $632,556,518 USD -47%
Common Stock, Value, Issued $6,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 46,743,000 shares -3.5%
Weighted Average Number of Shares Outstanding, Diluted 48,215,000 shares -7.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $719,887,000 USD -1.6%
Cost of Revenue $363,830,000 USD 1.6%
Research and Development Expense $85,844,000 USD 16%
Selling and Marketing Expense $43,885,000 USD 16%
General and Administrative Expense $85,925,000 USD 51%
Operating Income (Loss) $140,403,000 USD -32%
Nonoperating Income (Expense) $16,779,000 USD -7.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $123,624,000 USD -35%
Income Tax Expense (Benefit) $25,530,000 USD -14%
Net Income (Loss) Attributable to Parent $98,094,000 USD -39%
Earnings Per Share, Basic 2.1 USD/shares -36%
Earnings Per Share, Diluted 2.03 USD/shares -34%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $170,177,000 USD 12%
Accounts Receivable, after Allowance for Credit Loss, Current $143,560,000 USD 5.3%
Inventory, Net $176,890,000 USD 15%
Assets, Current $636,016,000 USD 19%
Deferred Income Tax Assets, Net $42,464,000 USD -40%
Property, Plant and Equipment, Net $310,567,000 USD 4.4%
Operating Lease, Right-of-Use Asset $42,931,000 USD -8.5%
Goodwill $3,402,000 USD 12%
Other Assets, Noncurrent $31,135,000 USD 20%
Assets $1,629,299,000 USD 3.3%
Accounts Payable, Current $32,592,000 USD 6.8%
Employee-related Liabilities, Current $26,318,000 USD 1.2%
Accrued Liabilities, Current $115,756,000 USD -8.5%
Liabilities, Current $158,156,000 USD -9%
Long-term Debt and Lease Obligation $608,749,000 USD 1.2%
Accrued Income Taxes, Noncurrent $5,926,000 USD -15%
Operating Lease, Liability, Noncurrent $37,684,000 USD -10%
Other Liabilities, Noncurrent $29,979,000 USD 43%
Liabilities $840,494,000 USD -0.55%
Accumulated Other Comprehensive Income (Loss), Net of Tax $5,314,000 USD 42%
Retained Earnings (Accumulated Deficit) $666,881,000 USD 17%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $788,805,000 USD 7.7%
Liabilities and Equity $1,629,299,000 USD 3.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 61,779,883 shares 1.5%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $170,412,000 USD 12%
Deferred Tax Assets, Valuation Allowance $23,273,000 USD 3.9%
Deferred Tax Assets, Gross $114,135,000 USD -19%
Operating Lease, Liability $45,612,000 USD -6.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $101,961,000 USD -36%
Lessee, Operating Lease, Liability, to be Paid $55,244,000 USD -6.9%
Property, Plant and Equipment, Gross $616,833,000 USD 8.4%
Operating Lease, Liability, Current $7,928,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $9,400,000 USD -0.02%
Lessee, Operating Lease, Liability, to be Paid, Year One $10,642,000 USD 11%
Operating Lease, Weighted Average Discount Rate, Percent 0.067 pure 6.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,632,000 USD -9.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three $8,738,000 USD -5.2%
Deferred Tax Assets, Operating Loss Carryforwards $24,032,000 USD 9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $14,315,000 USD 4.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four $8,595,000 USD 1.3%
Additional Paid in Capital $535,380,000 USD 5.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $14,129,000 USD 5.4%
Share-based Payment Arrangement, Expense $27,277,000 USD 12%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%